Sanofi and Orano Collaborate to Advance Next-Generation Radioligand Therapies

MedGenome Celebrates a Decade of Genomics Innovation

PathPresenter and Paige Partner to Drive Adoption of AI-Powered Digital Pathology and Image Management Workflows

Myriad Genetics and jscreen Announce Strategic Partnership to Expand Access to Preventative Genetic Testing

Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina

Lucid Diagnostics Secures Key Patent Allowance for EsoGuard Esophageal DNA Test

Myriad Genetics and Flatiron Health Collaborate to Expand Access to Genetic Testing Through EMR Integration

QIAGEN and Illumina Unveil New Solutions to Advance Liquid Biopsy and Next-Generation Sequencing

The Role of Biobanks in Advancing Precision Medicine

AstraZeneca and Daiichi Sankyo's Enhertu Secures Conditional Approval in China for HER2-Mutated NSCLC Treatment

SkylineDx Presents Breakthrough Data from Largest Melanoma Genomic Assay Trial at SMR Annual Meeting

Clario and PathAI Join Forces to Streamline GI Clinical Trials with Integrated Solutions

FDA Approves FoundationOne® Liquid CDx as Companion Diagnostic for Itovebi™ (inavolisib) to Identify Hormone Receptor-Positive, HER2-Negative Breast Cancer Patients with PIK3CA Mutation

Roche’s VENTANA CLDN18 (43-14A) RxDx Assay for Identifying Gastric and GEJ Cancer Patients Receives CE Mark Approval

Tempest and Roche Partner to Advance Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial